Repros Therapeutics (RPRX) Tops Q1 EPS by 2c
Repros Therapeutics (NASDAQ: RPRX) reported Q1 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Repros Therapeutics (NASDAQ: RPRX) reported Q1 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.